Detalhe da pesquisa
1.
Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(7): 753-782, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433437
2.
Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation.
Oncologist
; 26(7): e1104-e1109, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33742489
3.
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(4): 439-457, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33845462
4.
Immune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration-Approved Indications for Immunotherapy.
Oncologist
; 25(8): 669-679, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31943525
5.
A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancer.
Invest New Drugs
; 38(3): 821-830, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31338636
6.
Pancreatic Adenocarcinoma, Version 1.2019.
J Natl Compr Canc Netw
; 17(3): 202-210, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30865919
7.
Dual Src and EGFR inhibition in combination with gemcitabine in advanced pancreatic cancer: phase I results : A phase I clinical trial.
Invest New Drugs
; 36(3): 442-450, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28990119
8.
Phase II study of the Multikinase inhibitor of angiogenesis, Linifanib, in patients with metastatic and refractory colorectal cancer expressing mutated KRAS.
Invest New Drugs
; 35(4): 491-498, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28353122
9.
A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers.
Invest New Drugs
; 35(1): 95-104, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27853997
10.
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(8): 1028-1061, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28784865
11.
Safety and Efficacy of Avelumab in Small Bowel Adenocarcinoma.
Clin Colorectal Cancer
; 21(3): 236-243, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35450836
12.
First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study.
J Clin Oncol
; 40(2): 161-170, 2022 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637336
13.
External Validation of a Clinical Score for Patients With Neuroendocrine Tumors Under Consideration for Peptide Receptor Radionuclide Therapy.
JAMA Netw Open
; 5(1): e2144170, 2022 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35044469
14.
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors.
J Immunother Cancer
; 10(10)2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36316061
15.
Treatment of early-stage pancreatic cancer.
Oncology (Williston Park)
; 25(2): 182-9, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21456390
16.
Recent advances in the treatment of pancreatic cancer.
F1000Res
; 92020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32148767
17.
Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal Tumors.
Clin Cancer Res
; 26(7): 1555-1562, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31924737
18.
Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer.
Clin Cancer Res
; 26(20): 5348-5357, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32694153
19.
Phase I Trial of Trametinib with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer.
Clin Cancer Res
; 26(13): 3117-3125, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32253228
20.
Advanced pancreatic cancer clinical trials: The continued underrepresentation of older patients.
J Geriatr Oncol
; 10(4): 540-546, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30573201